Comparative Trial Via Tranforaminal Approach Versus Epidural Catheter Via Interlaminar Approach

PHASE4CompletedINTERVENTIONAL
Enrollment

120

Participants

Timeline

Start Date

September 15, 2017

Primary Completion Date

April 15, 2020

Study Completion Date

August 19, 2020

Conditions
Cervical Radiculopathy
Interventions
PROCEDURE

Transforaminal ESI with dexamethasone

Catheter-targeted ESI via interlaminar access at the C7-T1 level with dexamethasone sodium phosphate 1.5 mL (10 mg/mL) and 1 ml 1% lidocaine (total volume 2.5 mL).

PROCEDURE

Transforaminal catheter-targeted ESI with triamcinolone

Catheter-targeted ESI via interlaminar access at the C7-T1 level with triamcinolone acetonide 2 mL (40mg/mL) and 1 ml 1% lidocaine (total volume 3 mL).

DRUG

Dexamethasone Sodium Phosphate 10 MG/ML

Transforaminal ESI with dexamethasone 1.5 mL of dexamethasone sodium phosphate in group #1

DRUG

Lidocaine

1 mL of 1% lidocaine as diluent for the steroid in both group #1 and group #2

DRUG

Triamcinolone Acetonide 40mg/mL

Transforaminal catheter-targeted ESI with triamcinolone acetonide 2 mL in group #2

Trial Locations (1)

84108

University of Utah Orthopaedic Center, Salt Lake City

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Epimed

INDUSTRY

lead

University of Utah

OTHER